SPI Pharma partners Azelis Americas
Supply Chain

SPI Pharma partners Azelis Americas

In the agreement, Marcor, an Azelis Americas company, will distribute the SPI Pharma product lines in the United States, and Azelis Canada Pharma Division will be responsible for the Canadian marketplace

  • By IPP Bureau | August 07, 2021

SPI Pharma, a leading supplier of solutions to pharmaceutical formulation marketers, has announced an exclusive agreement with Azelis Americas, a leading innovation service provider in the specialty chemicals and food ingredients industry.

In the agreement, Marcor, an Azelis Americas company, will distribute the SPI Pharma product lines in the United States, and Azelis Canada Pharma Division will be responsible for the Canadian marketplace.

The partnership extends the organoleptic excipients in Azelis' range, complementing the existing starches, sugars and flavors. This alliance also expands Azelis' antacid actives for pharmaceuticals and highly bioavailable metal salts for the nutraceuticals market.

SPI Pharma delivers a wide range of solutions to the pharmaceutical and nutraceutical markets from excipients and antacid actives to formulation development and services. This agreement covers product lines including mannitol, fructose, maltose, antacid actives, metal salts, surface modified sodium bicarbonate, ODT drug delivery systems and vaccine adjuvants. The additional products from SPI Pharma, in combination with existing flavors and sweeteners in Azelis' portfolio, allow for new formulations, chewable tablets, nutraceutical tablets, and more.

Scott Thomson, CEO, SPI Pharma said, "The Azelis network of application labs and their formulation expertise will add depth to SPI Pharma's ability to deliver on our goal of solving formulation challenges for our customers. With the Azelis Americas team of sales, service and technical experts behind us, we look forward to the great results they will bring in the US and Canada."

Frank Bergonzi, CEO and President, Azelis Americas said, "SPI Pharma is a leader in providing pharmaceutical solutions. With the new excipient product lines available from SPI Pharma in combination with our existing products, our customers will now have access to the broadest range of specialty ingredients in the market."

Upcoming E-conference

Other Related stories

Startup

Digitization